MedPath

Role of Shubhdeep Swasha Hara Pill in management of Shwasa roga (Asthma)

Phase 4
Conditions
Health Condition 1: J454- Moderate persistent asthma
Registration Number
CTRI/2020/01/022961
Lead Sponsor
Self
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)Patients presenting with clinical features of Bronchial Asthma 2)Patients aged between 16-70 years with irrespective of gender 3)Peak Expiratory flow Rate more than 80 Lit/min & less than 300 Lit/min.

Exclusion Criteria

1)Patient aged less than 16 yr and more than 70 yrs 2)Peak Expiratory flow Rate less than 80 Lit/min are excluded 3)Asthma in pregnancy 4)Patients with severe attacks of Bronchial Asthma 5)Patients of Bronchial Asthma also suffering from other systemic disorders 6)The Bronchial asthma, associated with complications like emphysema and cor pulmonale. •

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath